ATE554385T1 - Verfahren zur selektiven untersuchung von adiponectin-multimeren - Google Patents

Verfahren zur selektiven untersuchung von adiponectin-multimeren

Info

Publication number
ATE554385T1
ATE554385T1 AT09004308T AT09004308T ATE554385T1 AT E554385 T1 ATE554385 T1 AT E554385T1 AT 09004308 T AT09004308 T AT 09004308T AT 09004308 T AT09004308 T AT 09004308T AT E554385 T1 ATE554385 T1 AT E554385T1
Authority
AT
Austria
Prior art keywords
adiponectin
electrophoresed
kda
sds
exhibits
Prior art date
Application number
AT09004308T
Other languages
English (en)
Inventor
Hiroyuki Ebinuma
Hirokazu Yago
Yuka Akimoto
Osamu Myazaki
Takashi Kadowaki
Toshimasa Yamauchi
Kazuo Hara
Original Assignee
Sekisui Medical Co Ltd
Toudai Tlo Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Medical Co Ltd, Toudai Tlo Ltd filed Critical Sekisui Medical Co Ltd
Application granted granted Critical
Publication of ATE554385T1 publication Critical patent/ATE554385T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/042—Disorders of carbohydrate metabolism, e.g. diabetes, glucose metabolism
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/32—Cardiovascular disorders
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT09004308T 2003-10-15 2004-10-15 Verfahren zur selektiven untersuchung von adiponectin-multimeren ATE554385T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2003354930 2003-10-15

Publications (1)

Publication Number Publication Date
ATE554385T1 true ATE554385T1 (de) 2012-05-15

Family

ID=34463157

Family Applications (2)

Application Number Title Priority Date Filing Date
AT09004308T ATE554385T1 (de) 2003-10-15 2004-10-15 Verfahren zur selektiven untersuchung von adiponectin-multimeren
AT04792477T ATE439590T1 (de) 2003-10-15 2004-10-15 Verfahren zum selektiven testen von adiponectinmultimeren

Family Applications After (1)

Application Number Title Priority Date Filing Date
AT04792477T ATE439590T1 (de) 2003-10-15 2004-10-15 Verfahren zum selektiven testen von adiponectinmultimeren

Country Status (12)

Country Link
US (2) US7608405B2 (de)
EP (2) EP2071333B1 (de)
JP (1) JP4677545B2 (de)
KR (1) KR101206338B1 (de)
CN (1) CN1867828B (de)
AT (2) ATE554385T1 (de)
AU (1) AU2004282754B9 (de)
CA (1) CA2542824C (de)
DE (1) DE602004022575D1 (de)
ES (2) ES2383259T3 (de)
MX (1) MXPA06004235A (de)
WO (1) WO2005038457A1 (de)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10303974A1 (de) 2003-01-31 2004-08-05 Abbott Gmbh & Co. Kg Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung
DE602004022968D1 (de) * 2003-11-07 2009-10-15 Merck & Co Inc Ie behandlung mti insulinsensibilisatoren
CA2614340A1 (en) * 2005-07-21 2007-06-07 Biovendor Laboratory Medicine, Inc. Method for determining the concentration of the adipocytic form of the fatty acid binding protein (a-fabp, fabp4, p2)
EP2289909B1 (de) 2005-11-30 2014-10-29 AbbVie Inc. Screeningsverfahren, Verfahren zur Reinigung von nicht-diffundierenden Beta-Oligomeren, selektive Antikörper gegen genannten nichtdiffundierende Beta-Oligomere und Verfahren zur Herstellung von genannten Antikörpern
KR101667623B1 (ko) 2005-11-30 2016-10-19 애브비 인코포레이티드 아밀로이드 베타 단백질에 대한 모노클로날 항체 및 이의 용도
US8455626B2 (en) 2006-11-30 2013-06-04 Abbott Laboratories Aβ conformer selective anti-aβ globulomer monoclonal antibodies
EP2486928A1 (de) * 2007-02-27 2012-08-15 Abbott GmbH & Co. KG Verfahren zur Behandlung von Amyloidosen
US8017573B2 (en) 2007-11-30 2011-09-13 Siemens Healthcare Diagnostics Inc. Adiponectin receptor fragments and methods of use
CN102016073A (zh) 2008-02-29 2011-04-13 Isis创新有限公司 诊断方法
CA2716852C (en) * 2008-02-29 2016-11-15 Sekisui Medical Co., Ltd. High-molecular-weight adiponectin measurement method
WO2009141352A2 (en) 2008-05-20 2009-11-26 F. Hoffmann-La Roche Ag Risk analysis in patients with and without metabolic syndrome
US9817001B2 (en) 2008-05-27 2017-11-14 Boston Heart Diagnostics Corporation Methods for determining LDL cholesterol treatment
WO2010123720A1 (en) 2009-04-23 2010-10-28 Siemens Healthcare Diagnostics Inc. Monomeric and dimeric forms of adiponectin receptor fragments and methods of use
CA2736722A1 (en) * 2008-09-11 2010-03-18 F.Hoffmann-La Roche Ag Natriuretic peptides and adiponectin in subjects with a metabolic syndrome
US8470541B1 (en) 2008-09-27 2013-06-25 Boston Heart Diagnostics Corporation Methods for separation and immuno-detection of biomolecules, and apparatus related thereto
EP2353015A1 (de) * 2008-11-10 2011-08-10 F. Hoffmann-La Roche AG Relevanz der darmadipozytenfunktion bei typ-1-diabetes
EP2211182A1 (de) 2009-01-16 2010-07-28 Roche Diagnostics GmbH Verfahren zur Bewertung des Schweregrades einer Leberzirrhose
US8871518B2 (en) 2009-05-07 2014-10-28 Otsuka Pharmaceutical Co., Ltd. Monoclonal antibody for analyzing high-molecular weight adiponectin and utilization of same
EP2558494B1 (de) 2010-04-15 2018-05-23 AbbVie Inc. Amyloid-beta-bindende proteine
JP5685777B2 (ja) * 2010-04-28 2015-03-18 株式会社エヌビィー健康研究所 バーチャルウエスタンブロッティングシステム
CA2800458A1 (en) 2010-06-15 2011-12-22 F. Hoffmann-La Roche Ag Prediction and recognition of acute kidney injury after surgery
MX358739B (es) 2010-08-14 2018-09-03 Abbvie Inc Star Proteinas de union a amiloide beta.
EP2392927A1 (de) 2011-03-11 2011-12-07 F. Hoffmann-La Roche AG Diagnose von Stoffwechselstörungen in HIV-infizierten Patienten
EP2385372A1 (de) 2011-06-21 2011-11-09 Roche Diagnostics GmbH Nierenerkrankung in einer normal und nicht normal verlaufenden Schwangerschaft
EP2568291A1 (de) 2011-09-07 2013-03-13 Roche Diagnostics GmbH L-FABP-basierte Diagnose eines Nierentraumas nach einem akuten Ereignis oder nach einem chirurgischen Eingriff
EP3324184A1 (de) 2011-10-13 2018-05-23 Boston Heart Diagnostics Zusammensetzungen und verfahren zur behandlung und prävention von koronarer herzkrankheit
WO2014034168A1 (ja) * 2012-08-30 2014-03-06 Hashida Seiichi 早期腎障害の評価マーカーとその測定方法
US20140120559A1 (en) 2012-10-26 2014-05-01 Boston Heart Diagnostics Corporation Diabetes panel
US9828624B2 (en) 2013-07-24 2017-11-28 Boston Heart Diagnostics Corporation Driving patient compliance with therapy
JP6512590B2 (ja) * 2014-08-25 2019-05-15 メカノジェニック株式会社 メタボリックシンドローム発症の危険性の予測方法
EP3220810A4 (de) 2014-11-17 2018-05-16 Boston Heart Diagnostic Corporation Beurteilung des risikos für herz-kreislauf-erkrankungen
EP3320343B1 (de) * 2015-07-07 2020-09-02 Seqirus UK Limited Verfahren zur quantifizierung von immunogenem hämagglutinin
CN117054645A (zh) 2016-09-06 2023-11-14 富士瑞必欧株式会社 甲状腺球蛋白的测定方法及测定试剂
WO2018051965A1 (ja) 2016-09-13 2018-03-22 富士レビオ株式会社 心筋トロポニンの測定方法及び測定試薬
WO2020241443A1 (ja) 2019-05-24 2020-12-03 富士レビオ株式会社 サイログロブリンの測定方法及び測定試薬
CN114514427A (zh) 2019-09-27 2022-05-17 富士瑞必欧株式会社 乙型肝炎病毒核心相关抗原的免疫测定和用于其的试剂盒
CN111239421A (zh) * 2020-02-19 2020-06-05 安徽大千生物工程有限公司 一种定量检测脂联素adpn的胶乳增强免疫比浊试剂盒及其制备与应用方法
JP7606506B2 (ja) 2020-03-31 2024-12-25 富士レビオ株式会社 血中アミロイドβの免疫測定方法及びそのためのキット
CN111892907B (zh) * 2020-07-15 2021-11-02 广东省医疗器械研究所 一种白蛋白胶粘剂及其制备方法
US20250147029A1 (en) 2021-08-06 2025-05-08 Advanced Life Science Institute, Inc. Immunoassay for thyroglobulin and kit therefor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4444879A (en) * 1981-01-29 1984-04-24 Science Research Center, Inc. Immunoassay with article having support film and immunological counterpart of analyte
JP4424775B2 (ja) 1999-04-21 2010-03-03 大塚製薬株式会社 抗原蛋白質の検出方法
CN1281981A (zh) * 1999-07-26 2001-01-31 武汉埃克玛生物技术有限公司 血清低密度脂蛋白测定试剂
CN1111201C (zh) * 1999-11-04 2003-06-11 孙续国 低密度脂蛋白受体检测试剂及方法
JP4458622B2 (ja) 2000-05-26 2010-04-28 積水メディカル株式会社 免疫学的測定方法及び測定用試薬
JP4547696B2 (ja) 2001-06-07 2010-09-22 第一三共株式会社 肝硬変予防・治療剤
WO2003016906A1 (fr) 2001-08-17 2003-02-27 Rebio Gen, Inc. Procede de diagnostic ou de controle d'une erreur du metabolisme du saccharose

Also Published As

Publication number Publication date
JPWO2005038457A1 (ja) 2007-01-18
MXPA06004235A (es) 2007-02-14
EP1681566A4 (de) 2007-05-02
ATE439590T1 (de) 2009-08-15
CA2542824A1 (en) 2005-04-28
EP1681566B1 (de) 2009-08-12
US7608405B2 (en) 2009-10-27
ES2329582T3 (es) 2009-11-27
EP2071333B1 (de) 2012-04-18
WO2005038457A1 (ja) 2005-04-28
AU2004282754A1 (en) 2005-04-28
AU2004282754B2 (en) 2009-11-12
EP2071333A3 (de) 2009-07-08
KR20060132571A (ko) 2006-12-21
US20070042424A1 (en) 2007-02-22
EP2071333A2 (de) 2009-06-17
US8039223B2 (en) 2011-10-18
JP4677545B2 (ja) 2011-04-27
AU2004282754B9 (en) 2009-12-10
DE602004022575D1 (de) 2009-09-24
CN1867828B (zh) 2010-09-29
KR101206338B1 (ko) 2012-12-03
US20090291461A1 (en) 2009-11-26
CA2542824C (en) 2013-08-27
ES2383259T3 (es) 2012-06-19
CN1867828A (zh) 2006-11-22
EP1681566A1 (de) 2006-07-19

Similar Documents

Publication Publication Date Title
ATE554385T1 (de) Verfahren zur selektiven untersuchung von adiponectin-multimeren
DE69638004D1 (de) Protein-färbung mittels merocyanin farbstoffe
DE60140773D1 (de) Polypeptide zur Bindung an das B-Lymphozyten-stimulatorische Protein (BLyS)
Manabe et al. Identification map of human plasma proteins: Micro two‐dimensional electrophoresis followed by multiple immunoreplica technique
ATE516304T1 (de) Nrg-2 nukleinsäuren, polypeptide und diagnostische / therapeutische methoden
EP1623227A4 (de) Proteine, sensoren und verfahren zur charakterisierung von analyten damit
ATE438657T1 (de) Charakterisierung von granulozytischer ehrlichia und methoden für ihre verwendung.
ATE474855T1 (de) Polyklonaler-monoklonaler-elisa-assay zum nachweis von n-terminalem probnp
MX9200709A (es) Activacion mejorada de proteinas recombinadas. activacion mejorada de proteinas recombinadas.
SE8802944L (sv) Material foer lapptestning
Crettaz et al. Proteomics of methylene blue photo‐treated plasma before and after removal of the dye by an absorbent filter
ATE322688T1 (de) Verfahren zur bestimmung der nitrosylierung von proteinen
DE60325382D1 (de) Verfahren zur diagnose von gebärmutterhalskrebs
DE60331857D1 (de) Markerproteine zur diagnose einer lebererkrankung und verfahren zur diagnose einer lebererkrankung damit
DE60203599D1 (de) Methode zur Inaktivierung von TSE
IL162568A0 (en) fluorescent protein from aequorea coerulscens and uses thereof
CA2471026A1 (en) Method of electrophoresing protein
BRPI0406265A (pt) Método para análise eletroforética capilar, métodos para pesquisa e tipagem de proteìnas monoclonais, processo para preparação de anticorpos modificados, anticorpos modificados, kit para detecção e tipagem de proteìnas monoclonais e uso de anticorpos
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
EP1560025A3 (de) Marker spezifisch für Diabetes
ATE383418T1 (de) Verfahren und zusammensetzungen zur bestimmung glycierter proteine
Manabe et al. Identification of bovine fetal and adult serum/plasma proteins by two‐dimensional electrophoresis and immunochemical staining
Kustos et al. Effect of iron restriction on outer membrane protein composition of Pseudomonas strains studied by conventional and microchip electrophoresis
DE60230988D1 (de) Proteine in der diabetes-proteomanalyse
Carrell et al. High resolution electrophoretic analysis of human fibrinogen and its crosslinked intermediates